Neuroscientific Biopharmaceuticals (ASX:NSB) Common Stock: A$34.26 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Neuroscientific Biopharmaceuticals Common Stock?

Neuroscientific Biopharmaceuticals ASX:NSB Common Stock is A$34.26 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Neuroscientific Biopharmaceuticals's quarterly common stock increased from Dec. 2024 (A$25.52 Mil) to Jun. 2025 (A$34.26 Mil) but then stayed the same from Jun. 2025 (A$34.26 Mil) to Dec. 2025 (A$34.26 Mil).

Neuroscientific Biopharmaceuticals's annual common stock increased from Jun. 2023 (A$25.28 Mil) to Jun. 2024 (A$25.52 Mil) and increased from Jun. 2024 (A$25.52 Mil) to Jun. 2025 (A$34.26 Mil).

Neuroscientific Biopharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Neuroscientific Biopharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuroscientific Biopharmaceuticals Common Stock Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial 25.28 25.28 25.28 25.52 34.26

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.52 25.52 25.52 34.26 34.26

Neuroscientific Biopharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$34.26 Mil mean?
Neuroscientific Biopharmaceuticals (ASX:NSB) has a Common Stock of A$34.26 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Neuroscientific Biopharmaceuticals and its competitors.
Is Neuroscientific Biopharmaceuticals' Common Stock too high?
Neuroscientific Biopharmaceuticals' current Common Stock is A$34.26 Mil.
How does Neuroscientific Biopharmaceuticals' Common Stock compare to VRTX and REGN?
Neuroscientific Biopharmaceuticals' Common Stock of A$34.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Neuroscientific Biopharmaceuticals and its competitors. Neuroscientific Biopharmaceuticals's current Common Stock is A$34.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuroscientific Biopharmaceuticals stock overvalued right now?
Neuroscientific Biopharmaceuticals (ASX:NSB) has a current Common Stock of A$34.26 Mil. The current Common Stock is A$34.26 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Neuroscientific Biopharmaceuticals (ASX:NSB), the current Common Stock is A$34.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neuroscientific Biopharmaceuticals Business Description

Address 216 Street Georges Terrace, Level 4, Perth, WA, AUS, 6000
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and treatments for neurodegenerative diseases through preclinical studies of patented technologies.